Pharmafile Logo

Pharma-Exclusive Webinar: Redefining Engagement in the AI Era

Join Impetus Digital’s pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static programs into high-retention, interactive experiences without enterprise overhead.

- PMLiVE

 

While artificial intelligence has generated endless conversation across life sciences, moving from theoretical promise to practical execution remains a major hurdle for many teams. Designed specifically to cut through the industry noise, this pharma-exclusive webinar reveals how forward-thinking Medical Affairs, Med Ed, and Commercial leaders are deploying fully compliant, low-friction AI tools and interactive virtual workflows without incurring enterprise overhead or navigating complex open-web security risks.

Attendees will discover how to elevate static presentations and traditional learning modules into dynamic, high-retention environments—utilizing interactive AI presenters, dynamic scenario branching, and conversational AI peers like Ruby to transform passive participants into active, high-retention collaborators. Beyond showcasing creative, multi-departmental use cases and real-world client workflows, the session breaks down how to capture real-time market intelligence straight from live analytics dashboards—surfacing instant audience confidence scores, clinical knowledge gaps, and trending questions. Ultimately, this masterclass demystifies the adoption process, equipping agile life science teams with actionable best practices to boost knowledge retention by 4x, optimize project budgets, and achieve high-velocity outcomes.


Click here to learn more and register

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Protecting Ownership of Technological & Pharmaceutical Innovation

Joshua Goldberg, Co-Managing Partner at Nath, Goldberg & Meyer, discusses key intellectual property issues and pitfalls in the digital health space, the importance of international patent protection, and why it’s…

Measuring Vital Health Indicators Through Your Camera

Dr. Keith Thompson, CMO at Nuralogix, dives into virtual care, telemedicine, and advanced digital health tools for improving primary care workflows and population health. He also shares his insights into…

VR/AR Applications for Training and Healthcare

Mike Waldron, CEO and Co-Founder of Propel VR, discusses how virtual reality (VR) and augmented reality (AR) can be leveraged in the healthcare industry, including specific applications of VR/AR for…

Forging Innovative Solutions by Merging Art and Science

Ariel Garten, Founder & Chief Evangelism Officer at Muse, explores many exciting topics such as the idea of whether art and beauty can be broken down into biological codes, the…

Expanding Access to High-Quality Healthcare

Dr. Jason Cross, Co-founder & Chief Strategy Officer at Rymedi, dives into Connected Health, including how it can be used to expand access to high-quality healthcare, current barriers to its…

Developing Innovative Digital Strategies to Engage Patients

Caitlin Wagner, Associate Marketing Director at Pharming, shares her expertise on innovative patient engagement strategies, including the roles of mobile apps and social media, the impact of the COVID-19 pandemic…

The New Normal: Upcoming Trends in Clinical Trials

Samuel Searcy, Founder & CEO of CliniStart, shares his expert insights into trends, current gaps, and future predictions for clinical trials. Among many other things, we also dive into his…

Digitizing Cardiac Rehab to Capture and Retain More Patients

Dr. Harsh Vathsangam, CEO & Co-Founder of Moving Analytics, shares his expertise on mobile health and discusses how it can be used to improve patient adherence and access to cardiac…

Lesson Learned from the Pandemic

Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China and how that…

The Ongoing Evaluation of Medical Affairs

Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer, discusses a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work…